Laboratory-based calculation of coronary heart disease risk in a hospital diabetic clinic.

This publication has 11 references indexed in Scilit:

• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998
• Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels
  JAMA, 1998
• Statins and hypercholesterolaemia: UK Standing Medical Advisory Committee guidelines.
  The Lancet, 1997
• Effects of Cigarette Smoking, Diabetes, High Cholesterol, and Hypertension on All-Cause Mortality and Cardiovascular Disease Mortality in Mexican Americans: The San Antonio Heart Study
  American Journal of Epidemiology, 1996
• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
  New England Journal of Medicine, 1996
• Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table
  The Lancet, 1996
• Guidelines for managing raised blood pressure
  BMJ, 1996
• Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged men
  The American Journal of Cardiology, 1996
• U.K. Prospective Diabetes Study 16: Overview of 6 Years' Therapy of Type II Diabetes: A Progressive Disease
  Diabetes, 1995
• Cardiovascular disease risk profiles
  American Heart Journal, 1991